Загрузка...
Efficacy of Icotinib treatment in patients with stage IIIb/IV non-small cell lung cancer
BACKGROUND: To evaluate the efficacy and safety of Icotinib – an orally administered, highly potent selective inhibitor of epidermal growth factor receptor (EGFR) and its active mutations, in the treatment of patients with advanced non-small cell lung cancer (NSCLC). METHODS: A total of 101 patients...
Сохранить в:
| Опубликовано в: : | Thorac Cancer |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BlackWell Publishing Ltd
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704301/ https://ncbi.nlm.nih.gov/pubmed/26767007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12085 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|